Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission.
Yao LvYue LouGan YangYouyou LuoJin-Gan LouQi ChengJindan YuYouhong FangHong ZhaoKerong PengJie ChenPublished in: Gastroenterology research and practice (2022)
Our study suggested that EEN treatment is similar with IFX therapy in short-term outcomes, and EEN+6-MP/MTX treatment is comparable with IFX+IFX therapy in long-term outcomes.